A. Rodzajewska, W. Kuryło, and K. Szklener, “Impressive clinical response following combined BRAF and MEK inhibition in a low-grade serous ovarian carcinoma patient with a BRAF V600E mutation”, J Educ Health Sport, vol. 31, no. 1, pp. 138–147, Aug. 2023.